NCT01824836 - A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS) | Biotech Hunter

Enrollment

1,046

Participants

Timeline

Start Date

June 11, 2013

Primary Completion Date

June 9, 2022

Study Completion Date

December 31, 2026

Conditions

Estrogen Receptor-positive Breast CancerMusculoskeletal ComplicationsProgesterone Receptor-positive Breast CancerRecurrent Breast CancerStage IA Breast CancerStage IB Breast CancerStage II Breast CancerStage IIIA Breast CancerStage IIIB Breast CancerStage IIIC Breast Cancer

Interventions

DRUG

anastrozole

Given PO

Trial Locations (2)

02215

Eastern Cooperative Oncology Group, Boston

07018-1095

Veterans Adminstration New Jersey Health Care System, East Orange

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

ECOG-ACRIN Cancer Research Group

NETWORK